S. . Kolageri, S. Hemanth, and M. . Parit, “In-silico ADME prediction and molecular docking study of novel benzimidazole-1,3,4-oxadiazole derivatives as CYP51 inhibitors for antimicrobial activity”, J. Appl. Pharm. Res., vol. 10, no. 3, pp. 28-38, Sep. 2022.